Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide

J Tamargo, JY Le Heuzey, P Mabo - European journal of clinical …, 2015 - Springer
Purpose The therapeutic index (TI) is the range of doses at which a medication is effective
without unacceptable adverse events. Drugs with a narrow TI (NTIDs) have a narrow …

From pulsus to pulseless: the saga of cardiac alternans

JN Weiss, A Karma, Y Shiferaw, PS Chen… - Circulation …, 2006 - Am Heart Assoc
Computer simulations and nonlinear dynamics have provided invaluable tools for
illuminating the underlying mechanisms of cardiac arrhythmias. Here, we review how this …

The cardiac sodium channel: gating function and molecular pharmacology

JR Balser - Journal of molecular and cellular cardiology, 2001 - Elsevier
Cardiac sodium (Na) channels are dynamic molecules that undergo rapid structural
changes in response to the changing electrical field in the myocardium. Inherited mutations …

Genetic control of sodium channel function

HL Tan, CR Bezzina, JPP Smits… - Cardiovascular …, 2003 - academic.oup.com
Sodium ion (Na) influx through cardiac Na channels triggers the action potential in cells of
the working myocardium and the specialized conduction system. Na channels thus act as …

Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels

K Fukuda, SS Davies, T Nakajima, BH Ong… - Circulation …, 2005 - Am Heart Assoc
Sudden cardiac death attributable to ventricular tachycardia/fibrillation (VF) remains a
catastrophic outcome of myocardial ischemia and infarction. At the same time, conventional …

Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs

S Nattel - Cardiovascular research, 1998 - academic.oup.com
The major limitation to antiarrhythmic drug therapy is the risk of arrhythmia promotion, or
'proarrhythmia.'This complication may be lethal, and greatly restricts the value of …

Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions

S Nattel, BN Singh - The American journal of cardiology, 1999 - Elsevier
Since the use of cinchona bark to treat heart palpitations in the 1700s, antiarrhythmic drug
therapy has developed with the discovery of new compounds and the identification of ionic …

Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects

PF Kirchhof, CL Fabritz, MR Franz - Circulation, 1998 - Am Heart Assoc
Background—Conduction block may be both antiarrhythmic and proarrhythmic. Drug-
induced postrepolarization refractoriness (PRR) may prevent premature excitation and …

Role of abnormal repolarization in the mechanism of cardiac arrhythmia

OE Osadchii - Acta physiologica, 2017 - Wiley Online Library
In cardiac patients, life‐threatening tachyarrhythmia is often precipitated by abnormal
changes in ventricular repolarization and refractoriness. Repolarization abnormalities …

Effects of Na+ channel and cell coupling abnormalities on vulnerability to reentry: a simulation study

Z Qu, HS Karagueuzian, A Garfinkel… - American Journal of …, 2004 - journals.physiology.org
The role of dynamic instabilities in the initiation of reentry in diseased (remodeled) hearts
remains poorly explored. Using computer simulations, we studied the effects of altered Na+ …